| |
|
Christopher Wright, M.A. Non Executive Director
Christopher
Wright is Chairman and a co-founder of EMAlternatives LLC in Washington
DC, an emerging markets focused private equity asset management
firm and a director of Merifin Capital Group, a private European
investment firm. [more]
|
|
|
Shane
Kelly - Chief Executive Officer.
Shane
has extensive experience in financing, operating and managing early
and mid size growth companies. [more]
|
|
|
Richard
White, Ph.D Non Executive Director
Richard has a wealth of experience in infectious disease drug discovery.
[more]
|
|
|
Sten
Verland, Ph.D Non Executive Director
Sten
Verland is founding partner at Sunstone Capital. His primary investment
focus includes drug development, vaccines and stem cells, and he
has more than 20 years experience as an international executive,
entrepreneur and venture investor in biotech companies as well as
pre-clinical and clinical CROs. Currently, Sten also serves as non-executive
chairman of Action Pharma A/S and Zymenex A/S. [more]
|
F2G
Ltd, PO Box 1, Lankro Way, Eccles, Manchester, M30 0BH
Tel +44 (0)161 785 1270 Fax +44 (0)161 785 1273 Email contact@f2g.com
|